U.S., May 30 -- ClinicalTrials.gov registry received information related to the study (NCT07614893) titled 'Clinician Notification to Increase Aspirin Prophylaxis for Preeclampsia Prevention' on May 22.
Brief Summary: Preeclampsia is a leading cause of maternal morbidity and mortality. Low-dose aspirin prophylaxis reduces preeclampsia risk among high-risk pregnant individuals but remains underused in routine clinical practice. This pragmatic cluster-randomized implementation trial will test whether clinician notification of elevated preeclampsia risk increases aspirin prophylaxis utilization among eligible pregnant individuals receiving outpatient obstetric care.
Clusters will be randomized to clinician notification versus usual care. In ...